22nd - 23rd June 2023

4th Annual MarketsandMarkets Single-Cell Omics Conference

Unleashing the Future Trends in Single-Cell Omics Technology

The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single cell technologies have opened new opportunities to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option.

Omics technologies helps in comprehensive examination of genome biology (Genomics), proteins (Proteomics) and RNA molecules (Transcriptomics) which in turn are used for drug discovery and development. Thus, these single cell omics prospects are much anticipated to revolutionise our adequacy to understand the magnitude of omics diversity occurring in our biological systems.

MarketsandMarkets is delighted to announce its 4th Annual Single-Cell Omics Conference scheduled to be held on 22nd-23rd June 2023 in Boston, USA. The conference will assimilate diverse sessions on a board prospective of novel research and development in the field of multi-omics research. The event encompasses the Researchers, Scientists from top universities and pharmaceutical companies from all around the globe and provides the platform to share the knowledge with academic peers and present their research papers and reports.


Key Highlights:

  • Single cell genomic analysis for cancer/cellular heterogeneity
  • Single Cell Transcriptional Profiling, Digital spatial profiling
  • Spatial Single cell genome analysis – Sequencing application
  • Single-Cell phenotyping
  • Application of multiplex imaging – Single cell and tissue imaging
  • Current & Emerging Tools and Data Analysis in Single Cell Omics
  • Single Cell Analysis in Drug Discovery & Development – Sample Preparation and Processing
  • Microfluidics Tools for Single Cell Analysis
  • Cancer Biomarker discovery
  • Nanopore Technology – A Potential Application in Functional Genomics

Why attend?

  • Witness live action how Single-Cell Omics technology is revolutionizing the future of Biomedical research
  • Quality insights and cohesiveness of key issues with respect to Single-Cell to be addressed
  • Discover the different avenues in application of Multi-Omics studies
  • Comprehend the current and future research avenues of Single-Cell Omics in drug discovery and development
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency

Who should attend?

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science, Microbiologists, Virologists, Pathologists
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science, Microbiologists, Virologists, Pathologists

Enquire Now

Sponsor/Exhibit Delegate
Asaf Rotem
Asaf Rotem
Senior Director, Astrazeneca
Mandovi Chatterjee
Mandovi Chatterjee
Director, Single Cell Core, Harvard Medical School
Paloma Cejas
Paloma Cejas
Assistant Director, Center for Functional Cancer Epigenetics (DFCI)
Lakshmi Kuttippurathu
Lakshmi Kuttippurathu
Associate Director, Computational Biology & Data Sciences, Lexicon Pharmaceuticals
Tom Lanz
Tom Lanz
Director of Multi-Omics and Biomarkers, Pfizer
Senior Representative, Proteome Sciences
Senior Representative, Proteome Sciences
Senior Representative, Akoya Biosciences
Senior Representative, Akoya Biosciences
Please contact [email protected] for speaking opportunity

Proteome Sciences


Akoya Biosciences

Exhibition Partner

MMI - Molecular Machines & Industries





Supporting Association
Association for Single Cell Analysis

Association for Single Cell Analysis